The company Enpresso GmbH:
Enpresso is a pioneering biotechnology company offering innovative microbial media solutions based on its patented EnBase® technology. The Enpresso growth system features a controllable substrate release mechanism that ensures robust and highly reproducible cultivations in microwell plates, shake flasks, and bioreactors. The EnBase® principle — inspired by fed-batch processes — enables precise nutrient control, resulting in significantly higher cell densities and improved functional protein yields.
Enpresso products are particularly well-suited for enhancing recombinant protein production in bacteria and yeast, especially when low product activity or difficult-to-express proteins pose a challenge.
Proven applications include the optimized production of complex targets such as RNase inhibitor, valinomycin synthetase, and antibody Fab fragments.
Website Enpresso GmbH